Sihuan Pharmaceutical Holdings Group Ltd. (SHPHY)

Market Cap	900.52M -45.0%
Revenue (ttm)	387.62M +25.5%
Net Income	44.43M
EPS	0.20
Shares Out	n/a
PE Ratio	22.34
Forward PE	n/a
Dividend	0.06 (1.27%)
Ex-Dividend Date	Jul 2, 2026

Volume	250
Open	4.395
Previous Close	4.355
Day's Range	4.395 - 4.395
52-Week Range	4.355 - 4.395
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 26, 2026

About SHPHY

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China, the United States, and internationally. It operates in three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic devices, body sculpturing, skin care, and other services, as well as non- or minimally invas...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,712
• Stock Exchange: OTCMKTS
• Ticker Symbol: SHPHY

Financial Performance

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 9, 2026

Data Sources Report a data error